How many antibiotics are produced by the genus Streptomyces?

@article{Watve2001HowMA,
  title={How many antibiotics are produced by the genus Streptomyces?},
  author={Milind G. Watve and Rashmi Tickoo and Maithili M. Jog and Bhalachandra D. Bhole},
  journal={Archives of Microbiology},
  year={2001},
  volume={176},
  pages={386-390}
}
Abstract. Streptomyces is the largest antibiotic-producing genus in the microbial world discovered so far. The number of antimicrobial compounds reported from the species of this genus per year increased almost exponentially for about two decades, followed by a steady rise to reach a peak in the 1970s, and with a substantial decline in the late 1980s and 1990s. The cumulative number shows a sigmoid curve that is much flatter than what a logistic equation would predict. We attempted to fit a… Expand
Antibiotics produced by Streptomyces.
TLDR
The most interesting property of Streptomyces is the ability to produce bioactive secondary metabolites, such as antifungals, antivirals, antitumorals, anti-hypertensives, immunosuppressants, and especially antibiotics. Expand
Antibiotics produced by Streptomyces Rudi
Streptomyces is a genus of Gram-positive bacteria that grows in various environments, and its shape resembles filamentous fungi. The morphological differentiation of Streptomyces involves theExpand
Antibiotic-producing ability by representatives of a newly discovered lineage of actinomycetes.
TLDR
These previously uncultured actinomycetes share several features with Streptomyces and related antibiotic-producing genera, and represent a promising source of novel antibiotics. Expand
Chapter 5. Applying the genetics of secondary metabolism in model actinomycetes to the discovery of new antibiotics.
TLDR
The idea that manipulating metabolic conditions and regulatory pathways can "awaken" silent gene clusters and lead to the discovery of novel antimicrobial activities is explored. Expand
RNA degradation and the regulation of antibiotic synthesis in Streptomyces.
TLDR
The enzymology of RNA degradation in Streptomyces is reviewed in comparison with what is known about the degradation pathways in Escherichia coli and other bacteria and the evidence supporting a role for RNase III as a global regulator of antibiotic production in S. coelicolor is reviewed. Expand
Rare actinomycetes: a potential storehouse for novel antibiotics
TLDR
It is argued that the likelihood of discovering a new compound having a novel chemical structure can be increased with intensive efforts in isolating and screening rare genera of microorganisms, particularly actinomycetes. Expand
Widespread predatory abilities in the genus Streptomyces
TLDR
It is shown here that Streptomyces are non-obligate epibiotic predators of other microorganisms and that predatory abilities are widespread in this genus and strengthen the association between epibiotics predation and antibiotic production. Expand
Unlocking the potential of novel taxa : a study on Actinoallomurus
TLDR
This project is part of a discovery programme designed to assess the metabolic potential of Actinoallomurus, a recently described genus within the Actinobacteria, and shows how the delivery of new potential drug candidates demands an always broader set of diverse tools to be applied. Expand
Identification and Characterization of Antibiotic-Producing Actinomycetes Isolates
TLDR
Characterization of a selected isolate has led to identification of a unique strain of actinomycetes showing broad-spectrum antibacterial and antifungal properties, which has been suggested that the strain might be producing LL-E19085-like antib bacterial and a flavone glycoside-like antIfungal antibiotics. Expand
CHARACTERIZATION OF ANTIMICROBIAL COMPOUNDS FROM STREPTOMYCES SP
Actinomycetes are Gram positive bacteria having high GC percent in their DNA. They are important from industrial point of view as they have immense capability for production of biologically activeExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 20 REFERENCES
THE ACTINOMYCETES AND THEIR ANTIBIOTICS.
  • S. Waksman
  • Biology, Medicine
  • Advances in applied microbiology
  • 1963
TLDR
This chapter provides an overview of some of the reviews and studies that have been initiated as a result of the discovery that actinomycetes form one of the most important groups of antibiotic-producing organisms. Expand
The 'K' selected oligophilic bacteria: a key to uncultured diversity?
TLDR
Evidence is given in support of a hypothesis that a large proportion, if not all, of the uncultured diversity from a variety of aquatic and terrestrial habitats are oligophilic (oligotrophic) bacteria. Expand
The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics
TLDR
This minireview reviews the status of research in this critical therapeutic area, reevaluate the potential of older, unexploited agents and review current approaches to the discovery of new agents, including the identification of new molecular targets for antibiotic action. Expand
16S rRNA sequences reveal numerous uncultured microorganisms in a natural community
TLDR
A culture-independent analysis of the composition of a well-studied hot spring microbial community, using a common but distinctive cellular component, 16S ri bosom al RNA, confirms speculations about the diversity of uncultured microorganisms it contains. Expand
A study of iterative type II polyketide synthases, using bacterial genes cloned from soil DNA: a means to access and use genes from uncultured microorganisms
To examine as randomly as possible the role of the beta-ketoacyl and acyl carrier protein (ACP) components of bacterial type II polyketide synthases (PKSs), homologs of the chain-length-factor (CLF)Expand
Harnessing the biosynthetic code: combinations, permutations, and mutations.
TLDR
This review considers the promise and challenges inherent in the combinatorial manipulation of PKS and NRPS structure in order to generate entirely "unnatural" products. Expand
Emergent antibiotic resistance: health risks and economic impact.
  • G. Cassell
  • Medicine
  • FEMS immunology and medical microbiology
  • 1997
Perhaps there is no greater challenge related to emerging infections than the parallel emergence of antibiotic resistance. The relative utility of available antibiotics is eroding, tipping theExpand
Combinatorial biosynthesis for new drug discovery.
  • C. Hutchinson
  • Biology, Medicine
  • Current opinion in microbiology
  • 1998
TLDR
Extensions of the approach to include deoxysugar biosynthesis genes have expanded the possibilities for making new microbial metabolites and discovering valuable drugs through the genetic engineering of bacteria. Expand
The Commonness, And Rarity, of Species
The purpose of this paper is to deduce, from a number of examples and from theoretical considerations, some plausible general law as to how abundance or commonness is distributed among species.Expand
Impact of Culture-Independent Studies on the Emerging Phylogenetic View of Bacterial Diversity
Our perspective on microbial diversity has improved enormously over the past few decades. In large part this has been due to molecular phylogenetic studies that objectively relate organisms.Expand
...
1
2
...